Internal Medicine, Hematology & Oncology · South Miami, FL
NPI
1972595668
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7029 SW 61st Ave
South Miami, FL, 33143
Phone (786) 456-8399
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
342 services
Medicare patients, 2024
39
Average age 73
Drug cost, 2024
$4.1M
1,205 prescriptions
Company payments, 2025
$2,028
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose A Fernandez Chavez was code 99214 (office e&m - established), 87 times for 27 patients. In total Jose A Fernandez Chavez billed 342 services in 13 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 87 | 27 | $96.79 | $8,421 |
By year: 2022 $2,450 for 83 services; 2023 $13K for 167 services; 2024 $20K for 342 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jose A Fernandez Chavez prescribed most often to Medicare patients was Anastrozole, with 204 prescriptions and refills. In total Jose A Fernandez Chavez wrote 1,205 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 204 | 218 | 35 | $2,109 |
| Prednisone Generic | 116 | 116 | 19 | $910 |
| Abiraterone Acetate Generic | 113 | 113 | 16 | $197K |
| Keytruda Pembrolizumab | 74 | 74 | 11 | $876K |
| Dexamethasone Generic | 63 | 63 | 24 | $961 |
| Exemestane Generic | 42 | 42 | Under 11 | $12K |
| Alendronate Sodium Generic | 35 | 39 | Under 11 | $223 |
| Xgeva Denosumab | 34 | 34 | Under 11 | $114K |
| Acyclovir Generic | 31 | 31 | Under 11 | $1,137 |
| Ibrance Palbociclib | 29 | 29 | Under 11 | $455K |
| Revlimid Lenalidomide | 28 | 28 | Under 11 | $505K |
| Erleada Apalutamide | 27 | 27 | Under 11 | $406K |
| Folic Acid Generic | 23 | 23 | Under 11 | $29.76 |
| Xtandi Enzalutamide | 22 | 22 | Under 11 | $324K |
| Levothyroxine Sodium Generic | 21 | 21 | Under 11 | $145 |
Brand drugs: 338 claims; generic drugs: 867 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose A Fernandez Chavez $2,028 ($2,028 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $415.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 17 | $415 |
| Pfizer Inc. PFE | 13 | $292 |
| Janssen Biotech, Inc. JNJ | 9 | $229 |
| Celgene Corporation BMY | 10 | $221 |
| Merck Sharp & Dohme LLC MRK | 7 | $155 |
| BeOne Medicines USA, Inc. ONC | 4 | $110 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $94.98 |
| Lilly USA, LLC LLY | 4 | $92.81 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $73.32 |
| Eisai Inc. 4523.T | 3 | $72.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.